Vendor Neutral Archive (VNA) Market By Deployment Mode-
Vendor Neutral Archive (VNA) Market By Vendor Type-
Vendor Neutral Archive (VNA) Market By Imaging Type-
Vendor Neutral Archive (VNA) Market By End User-
Vendor Neutral Archive (VNA) Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Vendor neutral archive (VNA) Market Snapshot
Chapter 4. Global Vendor neutral archive (VNA) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Deployment Model Estimates & Trend Analysis
5.1. by Deployment Model & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Deployment Model:
5.2.1. On-Premises VNA
5.2.2. Cloud-Based VNA
Chapter 6. Market Segmentation 2: by Vendor Type Estimates & Trend Analysis
6.1. by Vendor Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Vendor Type:
6.2.1. Independent Software Vendors (ISVs)
6.2.2. PACS Vendors
6.2.3. Infrastructure Vendors
Chapter 7. Market Segmentation 3: by Imaging Type Estimates & Trend Analysis
7.1. by Imaging Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Imaging Type:
7.2.1. Radiology VNAs
7.2.2. Cardiology VNAs
7.2.3. Pathology VNAs
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
8.2.1. Hospitals
8.2.2. Diagnostic Imaging Centers
8.2.3. Ambulatory Care Centers
8.2.4. Research and Academic Institutes
Chapter 9. Vendor neutral archive (VNA) Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Deployment Model, 2019-2031
9.1.2. North America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Vendor Type, 2019-2031
9.1.3. North America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Imaging Type, 2019-2031
9.1.4. North America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
9.1.5. North America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Deployment Model, 2019-2031
9.2.2. Europe Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Vendor Type, 2019-2031
9.2.3. Europe Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Imaging Type, 2019-2031
9.2.4. Europe Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
9.2.5. Europe Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Deployment Model, 2019-2031
9.3.2. Asia Pacific Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Vendor Type, 2019-2031
9.3.3. Asia-Pacific Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Imaging Type, 2019-2031
9.3.4. Asia Pacific Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
9.3.5. Asia Pacific Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Deployment Model, 2019-2031
9.4.2. Latin America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Vendor Type, 2019-2031
9.4.3. Latin America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Imaging Type, 2019-2031
9.4.4. Latin America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
9.4.5. Latin America Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Deployment Model, 2019-2031
9.5.2. Middle East & Africa Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Vendor Type, 2019-2031
9.5.3. Middle East & Africa Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by Imaging Type, 2019-2031
9.5.4. Middle East & Africa Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
9.5.5. Middle East & Africa Vendor neutral archive (VNA) Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agfa Healthcare
10.2.2. Ambra Health
10.2.3. Aro Systems
10.2.4. Aspyra, Llc
10.2.5. Bridgehead Software Ltd.
10.2.6. Canon Medical Systems Corporation
10.2.7. Canopy Partners
10.2.8. Carestream Health
10.2.9. Central Data Networks
10.2.10. Cerner
10.2.11. Creliohealth Inc.
10.2.12. Esaote Spa
10.2.13. Fujifilm Corporation
10.2.14. Ge Healthcare
10.2.15. Hyland Software, Inc.
10.2.16. Intelerad Medical Systems Incorporated
10.2.17. Koninklijke Philips N.V.
10.2.18. Medicasoft
10.2.19. Merative
10.2.20. MILLENSYS
10.2.21. Novarad Corporation
10.2.22. Omnipacs
10.2.23. Onepacs
10.2.24. Paxerahealth
10.2.25. Postdicom
10.2.26. Sectra Ab
10.2.27. Siemens Healthineers
10.2.28. Softteam Solutions Pvt. Ltd.
10.2.29. Visus Health It Gmbh
10.2.30. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.